ClinicalTrials.Veeva

Menu
C

Clinovacare Medical Research Center | West Columbia, SC

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Ranibizumab
EYE103
Norketotifen
Obeldesivir
Aflibercept
Bonjesta®

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 8 total trials

A Dose-masked Study of Intravitreal Remigromig (EYE103) in Participants With NVAMD or Macular Edema Following BRVO (Super Tuscan)

EYE-RES-104 is a randomized, dose-masked study of intravitreal remigromig (EYE103) in participants with neovascular age-related macular degeneration...

Enrolling
Neovascular Age-Related Macular Degeneration (NVAMD)
Branch Retinal Vein Occlusion (BRVO)
Drug: Aflibercept 2.0 mg
Drug: Remigromig

EYE-RES-103 is a randomized, double masked pivotal study to evaluate the efficacy and safety of 2 dose levels of remigromig (EYE103) in comparison wi...

Active, not recruiting
Diabetic Macular Edema (DME)
Drug: Ranibizumab
Drug: Remigromig

EYE-RES-102 is a randomized, double masked pivotal study to evaluate the efficacy and safety of 2 dose levels of remigromig (EYE103) in comparison wi...

Active, not recruiting
Diabetic Macular Edema (DME)
Drug: Remigromig
Drug: Ranibizumab

Endometriosis is a painful disorder of the uterus affecting 6-10% of women of childbearing age. Endometriosis affects daily activities, social relati...

Active, not recruiting
Endometriosis
Drug: Elagolix
Drug: Placebo

Trial sponsors

E
AbbVie logo
D
E
Gilead Sciences logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems